01 January 2009
Depression while on the lung transplantation waiting list
Katayoun Najafizadeh, Fariba Ghorbani, Ameneh Rostami, Anis Fard-Mausavi, Mohammad Lorgard-Dezfuli- Nejad, Seyed-Mehran Marashian, Mohsen Roshanpazooh, Elham Farrokhnia, Habib Emami, Mohammad-Reza MasjediAnn Transplant 2009; 14(2): 34-37 :: ID: 880530
Abstract
Background: Patients inflicted with severe illnesses are prone to depression, which tends to intensify the burden of the disease. Those awaiting organ transplantation cannot help but feel that they may not be fortunate enough to breathe through a new lung. Such sense of doom along with constraints imposed by the illness increases the likelihood of depression. We sought to investigate the presence of depression in a group of patients on the lung transplantation waiting list in Iran.
Material/Methods: This cross-sectional study, conducted between August and September 2007, recruited 64 candidates from a single lung transplantation clinic. The Beck Depression Inventory was employed to identify the presence and severity of depression. This 21-item questionnaire has a total score ranging from 0 to 63, with higher scores denoting more severe depressive symptoms. In an Iranian population, scores from 0 to 15 signify no problem, while scores from 16 to 30 indicate mild, 31 to 46 moderate, and 47 to 63 severe depression.
Results: The patient population was composed of 70.3% men and 29.7% women at a mean age of 36.6±13.6 years. 40.6% were single and 59.4% were married. Whereas 43.8% had no abnormal depressive symptoms, 37.5% had mild and 18.7% had moderate symptoms.
Conclusions: More than half of the patients on the lung transplantation waiting list had a degree of depression. Given the risk of non-compliance with treatment in depressives, it is advisable that lung transplantation candidates be screened for depression and diagnosed cases be referred for the treatment of depression.
Keywords: Lung Transplantation, Depression, psychological burden, chronic lung disease
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






